CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 46 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,768 | +28.6% | 3,052 | 0.0% | 0.00% | – |
| Q2 2023 | $4,486 | -24.6% | 3,052 | 0.0% | 0.00% | -100.0% |
| Q1 2023 | $5,951 | -13.3% | 3,052 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $6,867 | -1.9% | 3,052 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $7,000 | +16.7% | 3,052 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $6,000 | -33.3% | 3,052 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $9,000 | -35.7% | 3,052 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $14,000 | +75.0% | 3,052 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $8,000 | -11.1% | 3,052 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $9,000 | 0.0% | 3,052 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $9,000 | 0.0% | 3,052 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $9,000 | -10.0% | 3,052 | 0.0% | 0.00% | -50.0% |
| Q3 2020 | $10,000 | 0.0% | 3,052 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $10,000 | -9.1% | 3,052 | 0.0% | 0.00% | -33.3% |
| Q1 2020 | $11,000 | -31.2% | 3,052 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $16,000 | -11.1% | 3,052 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $18,000 | -5.3% | 3,052 | 0.0% | 0.00% | -25.0% |
| Q2 2019 | $19,000 | +5.6% | 3,052 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $18,000 | 0.0% | 3,052 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $18,000 | +5.9% | 3,052 | 0.0% | 0.00% | +33.3% |
| Q3 2018 | $17,000 | -10.5% | 3,052 | 0.0% | 0.00% | -25.0% |
| Q2 2018 | $19,000 | -5.0% | 3,052 | 0.0% | 0.00% | -20.0% |
| Q1 2018 | $20,000 | -9.1% | 3,052 | 0.0% | 0.01% | 0.0% |
| Q4 2017 | $22,000 | +4.8% | 3,052 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $21,000 | 0.0% | 3,052 | 0.0% | 0.01% | -16.7% |
| Q2 2017 | $21,000 | 0.0% | 3,052 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $21,000 | +23.5% | 3,052 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $17,000 | +13.3% | 3,052 | 0.0% | 0.01% | +20.0% |
| Q3 2016 | $15,000 | +7.1% | 3,052 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $14,000 | 0.0% | 3,052 | 0.0% | 0.01% | -16.7% |
| Q1 2016 | $14,000 | -12.5% | 3,052 | 0.0% | 0.01% | -14.3% |
| Q4 2015 | $16,000 | -11.1% | 3,052 | 0.0% | 0.01% | -22.2% |
| Q3 2015 | $18,000 | -5.3% | 3,052 | 0.0% | 0.01% | 0.0% |
| Q2 2015 | $19,000 | -5.0% | 3,052 | 0.0% | 0.01% | 0.0% |
| Q1 2015 | $20,000 | +11.1% | 3,052 | 0.0% | 0.01% | 0.0% |
| Q4 2014 | $18,000 | +12.5% | 3,052 | 0.0% | 0.01% | 0.0% |
| Q3 2014 | $16,000 | +14.3% | 3,052 | 0.0% | 0.01% | 0.0% |
| Q2 2014 | $14,000 | 0.0% | 3,052 | 0.0% | 0.01% | 0.0% |
| Q1 2014 | $14,000 | -12.5% | 3,052 | 0.0% | 0.01% | -18.2% |
| Q4 2013 | $16,000 | – | 3,052 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 286,655 | $541,778 | 0.01% |
| Renaissance Technologies | 555,763 | $1,050 | 0.00% |
| Oakworth Capital, Inc. | 3,052 | $5,768 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 188,164 | $354 | 0.00% |
| MORGAN STANLEY | 11,274 | $21,308 | 0.00% |
| BlackRock Inc. | 110,990 | $209,771 | 0.00% |
| Bank of New York Mellon Corp | 75,268 | $142,256 | 0.00% |
| Citadel Advisors | 32,400 | $61,236 | 0.00% |
| Citadel Advisors | 6,400 | $12,096 | 0.00% |
| Citadel Advisors | 5,933 | $11,213 | 0.00% |